Charlotte's Web Holdings (CWEB) Stock Overview
Engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
CWEB Community Fair Values
See what others think this stock is worth. Follow their fair value or set your own to get alerts.
Looking to be second time lucky with a game-changing new product
Key Takeaways Unicycive has successfully completed clinical development of its lead asset, Oxylanthanum Carbonate (OLC). OLC has been designed to improve on current phosphate binders by offering better efficacy, fewer pills, and improved tolerability over alternative treatments for hyperphosphatemia chronic kidney disease patients on dialysis.Read more

Charlotte's Web Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.78 |
| 52 Week High | CA$0.79 |
| 52 Week Low | CA$0.075 |
| Beta | 2.15 |
| 1 Month Change | 39.29% |
| 3 Month Change | 321.62% |
| 1 Year Change | 437.93% |
| 3 Year Change | 4.00% |
| 5 Year Change | -88.65% |
| Change since IPO | -91.96% |
Recent News & Updates
Charlotte's Web Holdings, Inc. (TSE:CWEB) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected
Jan 28Is Charlotte's Web Holdings (TSE:CWEB) A Risky Investment?
Jan 14Charlotte's Web Holdings, Inc.'s (TSE:CWEB) 30% Dip In Price Shows Sentiment Is Matching Revenues
Dec 06Recent updates
Shareholder Returns
| CWEB | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 34.5% | -13.2% | -3.6% |
| 1Y | 437.9% | 5.0% | 25.5% |
Return vs Industry: CWEB exceeded the Canadian Pharmaceuticals industry which returned 5% over the past year.
Return vs Market: CWEB exceeded the Canadian Market which returned 25.5% over the past year.
Price Volatility
| CWEB volatility | |
|---|---|
| CWEB Average Weekly Movement | 27.7% |
| Pharmaceuticals Industry Average Movement | 15.1% |
| Market Average Movement | 10.6% |
| 10% most volatile stocks in CA Market | 19.9% |
| 10% least volatile stocks in CA Market | 3.3% |
Stable Share Price: CWEB's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: CWEB's weekly volatility (28%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 112 | Bill Morachnick | www.charlottesweb.com |
Charlotte's Web Holdings, Inc. engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products. Its product categories include full-spectrum hemp extract oil tinctures, such as liquid products; gummies; capsules; soft-gels; CBD topical creams and lotions; broad-spectrum botanical CBD; functional mushrooms; and pet products under the Charlotte’s Web, CBD CLINIC, and CBD MEDIC brand names. The company’s products contain naturally occurring phytocannabinoids, including CBD, cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), terpenes, flavonoids, and other beneficial hemp compounds.
Charlotte's Web Holdings, Inc. Fundamentals Summary
| CWEB fundamental statistics | |
|---|---|
| Market cap | CA$111.78m |
| Earnings (TTM) | -CA$29.66m |
| Revenue (TTM) | CA$67.35m |
Is CWEB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CWEB income statement (TTM) | |
|---|---|
| Revenue | US$49.24m |
| Cost of Revenue | US$27.45m |
| Gross Profit | US$21.79m |
| Other Expenses | US$43.48m |
| Earnings | -US$21.69m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.14 |
| Gross Margin | 44.26% |
| Net Profit Margin | -44.04% |
| Debt/Equity Ratio | 527.9% |
How did CWEB perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/02 22:42 |
| End of Day Share Price | 2026/02/02 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Charlotte's Web Holdings, Inc. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kyle McPhee | ATB Cormark Historical (Cormark Securities) |
| Luke Hannan | Canaccord Genuity |
| Pablo Zuanic | Cantor Fitzgerald & Co. |